Despite a number of individual studies performed in bladder cancer patients, the prognostic value of RASSF1A methylation status in bladder cancer patient’s diagnosis and the relationship between RASSF1A methylation and pathological features or the tumor grade of bladder cancer remains controversial. Here, RASSF1 is linked to urinary bladder cancer.